Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
about
Social participation in patients with multiple sclerosis: correlations between disability and economic burden.The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis.Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.Multiple sclerosis: basic knowledge and new insights in perioperative management.Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?Type-I interferon pathway in neuroinflammation and neurodegeneration: focus on Alzheimer's disease.Predictors of the 10-year direct costs for treating multiple sclerosis.Cost of care according to disease-modifying therapy in Mexicans with relapsing-remitting multiple sclerosis.
P2860
Q33729957-2615DAF5-8080-49EA-B53F-E6A1A4E24705Q35798769-48A6E731-432D-4B07-9BD2-9632BA8FAC6BQ36240512-4859DE66-62F9-4B47-A35A-928C75B52EFEQ36908003-6AB77AB1-E0E9-472D-92E2-A3FD96CD05C2Q36953860-105D3C06-87FF-40DD-8F5E-DEDEBDBC0E88Q38130445-F020910F-13A3-4A54-BC34-5A632E5D9F53Q38570681-813CFDAF-6AB9-4BA0-831E-BB76E8651CDDQ38693735-88C22ABE-9410-4677-BCEA-E1A09192E5D6Q38847064-B37AA03C-A063-4686-ADAD-22CBBDB33CAEQ43647433-8C4580F2-DBC9-4B3D-96BB-2330C157D157
P2860
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@ast
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@en
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@nl
type
label
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@ast
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@en
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@nl
altLabel
Cost-effectiveness of disease-modifying therapies in multiple sclerosis
@en
prefLabel
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@ast
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@en
Cost-Effectiveness of Disease-Modifying Therapies in Multiple Sclerosis
@nl
P2860
P3181
P1476
Cost-effectiveness of disease-modifying therapies in multiple sclerosis
@en
P2093
Ali Manouchehrinia
Cris S. Constantinescu
P2860
P2888
P304
P3181
P356
10.1007/S11910-012-0291-6
P407
P577
2012-10-01T00:00:00Z
P5875
P6179
1036277151